Boston Scientific Corp (BSX)
90.00
-1.50
(-1.64%)
USD |
NYSE |
Nov 22, 16:00
89.98
-0.02
(-0.02%)
Pre-Market: 20:00
Boston Scientific Free Cash Flow: 1.892B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.892B |
| June 30, 2024 | 1.686B |
| March 31, 2024 | 1.553B |
| December 31, 2023 | 1.703B |
| September 30, 2023 | 1.615B |
| June 30, 2023 | 1.422B |
| March 31, 2023 | 1.172B |
| December 31, 2022 | 914.00M |
| September 30, 2022 | 524.00M |
| June 30, 2022 | 583.00M |
| March 31, 2022 | 918.00M |
| December 31, 2021 | 1.316B |
| September 30, 2021 | 1.748B |
| June 30, 2021 | 1.883B |
| March 31, 2021 | 1.52B |
| December 31, 2020 | 1.132B |
| September 30, 2020 | 1.131B |
| June 30, 2020 | 997.00M |
| March 31, 2020 | 937.00M |
| December 31, 2019 | 1.375B |
| September 30, 2019 | 621.00M |
| June 30, 2019 | 651.00M |
| March 31, 2019 | 51.00M |
| December 31, 2018 | -178.00M |
| September 30, 2018 | 496.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 457.00M |
| March 31, 2018 | 1.153B |
| December 31, 2017 | 976.00M |
| September 30, 2017 | 790.00M |
| June 30, 2017 | 338.00M |
| March 31, 2017 | 471.00M |
| December 31, 2016 | 674.00M |
| September 30, 2016 | 368.00M |
| June 30, 2016 | 808.00M |
| March 31, 2016 | 479.00M |
| December 31, 2015 | 178.00M |
| September 30, 2015 | 443.00M |
| June 30, 2015 | 395.00M |
| March 31, 2015 | 611.00M |
| December 31, 2014 | 984.00M |
| September 30, 2014 | 808.00M |
| June 30, 2014 | 706.00M |
| March 31, 2014 | 822.00M |
| December 31, 2013 | 821.00M |
| September 30, 2013 | 984.00M |
| June 30, 2013 | 1.005B |
| March 31, 2013 | 1.013B |
| December 31, 2012 | 1.032B |
| September 30, 2012 | 964.00M |
| June 30, 2012 | 1.052B |
Free Cash Flow Range, Past 5 Years
524.00M
Minimum
Sep 2022
1.892B
Maximum
Sep 2024
1.301B
Average
1.346B
Median
Free Cash Flow Benchmarks
| Baxter International Inc | 391.00M |
| Haemonetics Corp | 20.35M |
| ResMed Inc | 1.347B |
| Globus Medical Inc | 293.77M |
| Abbott Laboratories | 6.486B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.002B |
| Cash from Investing (Quarterly) | -1.427B |
| Cash from Financing (Quarterly) | 7.00M |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 384.00M |
| Free Cash Flow to Firm (Quarterly) | 753.38M |
| Free Cash Flow Yield | 1.42% |